Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/16/2026, 3:51:30 AM
    Content snapshot
    {
      "session_id": "sess_SDA-2026-04-15-gap-debate-20260410-112607-0a3749ea_20260416-035130",
      "round_number": 4,
      "agent_persona": "persona-synthesizer",
      "agent_backend": "minimax/MiniMax-M2.7",
      "action": "synthesize",
      "content": "\n\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"Microglial ABCA1/ABCG1 Dysfunction Drives Lipid Droplet Accumulation and Vulnerability\",\n      \"mechanism\": \"Downregulation of microglial cholesterol efflux transporters ABCA1/ABCG1—regulated by TREM2 but also by inflammatory cues—leads to PLIN2/LIPA-mediated lipid droplet accumulation that impairs amyloid clearance and promotes neuroinflammation.\",\n      \"target_gene\": \"ABCA1\",\n      \"confidence_score\": 0.75,\n      \"novelty_score\": 0.55,\n      \"feasibility_score\": 0.60,\n      \"impact_score\": 0.80,\n      \"composite_score\": 0.70,\n      \"testable_prediction\": \"Single-cell RNA-seq from vulnerable vs. resilient SEA-AD regions will show ABCA1/PLIN2 co-expression changes; ABCA1 agonist (CSF1R inhibitor or liver X receptor agonist) will reduce lipid droplets in iPSC-derived microglia.\",\n      \"skeptic_concern\": \"Difficulty dissociating TREM2-dependent vs. independent effects requires careful experimental design with TREM2 knockout controls.\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"TREM2 Hypofunction Permits Lipid Droplet Accumulation as a Vulnerability Mechanism\",\n      \"mechanism\": \"Partial TREM2 loss-of-function variants reduce microglial lipid sensing and APOE lipidation, creating a permissive state for lipid droplet accumulation that drives pro-inflammatory responses characteristic of vulnerable regions.\",\n      \"target_gene\": \"TREM2\",\n      \"confidence_score\": 0.70,\n      \"novelty_score\": 0.65,\n      \"feasibility_score\": 0.55,\n      \"impact_score\": 0.75,\n      \"composite_score\": 0.69,\n      \"testable_prediction\": \"SEA-AD transcriptomic data will show TREM2 expression correlating inversely with lipid metabolism genes (PLIN2, LIPA) in vulnerable regions; TREM2 R47H carriers will demonstrate enhanced lipid droplet signatures.\",\n      \"skeptic_concern\": \"Theorist's claim of TREM2-independence contradicts established TREM2-lipid biology; reframing as TREM2 hypofunction is required.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"APOE4-Mediated Saturation of Astrocyte Cholesterol Clearance Defines Regional Vulnerability\",\n      \"mechanism\": \"APOE4 astrocytes have reduced capacity to accept cholesterol from microglia via APOE lipidation, causing saturation of the microglial-astrocytic cholesterol shuttle and accumulation of lipid droplets in both cell types.\",\n      \"target_gene\": \"APOE\",\n      \"confidence_score\": 0.65,\n      \"novelty_score\": 0.70,\n      \"feasibility_score\": 0.50,\n      \"impact_score\": 0.85,\n      \"composite_score\": 0.68,\n      \"testable_prediction\": \"APOE4 carriers in SEA-AD cohort will show elevated PLIN2 and reduced ABCG1 expression in vulnerable regions vs. APOE3/2 carriers; astrocyte-microglia co-culture with APOE4 will demonstrate cholesterol accumulation.\",\n      \"skeptic_concern\": \"Requires large enough stratified subcohort within SEA-AD to detect APOE genotype effects on lipid signatures.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"Microglial lipid droplet accumulation robustly associates with AD vulnerability across multiple independent datasets\",\n    \"The ABCA1/ABCG1-PLIN2/LIPA axis is a credible molecular pathway linking lipid dysregulation to microglial dysfunction\",\n    \"TREM2 signaling intersects with lipid metabolism, though the precise dependency requires further elucidation\"\n  ],\n  \"dissent_points\": [\n    \"Theorist insists on TREM2-independent mechanism while Skeptic and Expert agree TREM2 is mechanistically central to this pathway\"\n  ],\n  \"debate_summary\": \"The debate converged on lipid droplet accumulation in microglia as a key vulnerability signature, but diverged on TREM2's role—the Skeptic and Expert correctly identified the Theorist's TREM2-independence claim as mechanistically untenable, while the Expert endorsed reframing the hypothesis around downstream ABCA1/ABCG1 dysfunction. The highest-ranked hypotheses now integrate TREM2 biology with testable predictions for SEA-AD transcriptomic validation and APOE genotype stratification.\"\n}",
      "tokens_used": "1002"
    }